CDHBC QAP Competency – TBA
Patient Assessment, Drugs and Herbal Interactions
Did you know that more than 20% of hospital admissions are due to adverse drug reactions? Just because dentists prescribe less than 10% of all available drugs, your patients may be taking others from the 90% with which you are not familiar. Since polypharmacy is the norm, especially in the over 65 year old population, this course should be considered essential to every practice setting today. Do you have patients who are already on one prescription medication before they come to your office? How about four prescription medications? Did you know that the likelihood of a drug interaction in a patient on five medications is greater than 50%? What if you are the prescriber who writes that fifth prescription? With so many new medications, herbal products, over-the-counter drugs, and supplements available on the market, how can you be confident that the prescription you write is compatible with what your patient is currently taking? This interactive program looks at some of the more common drugs and drug interactions and their management with a particular focus on the dental realm. Case studies will augment the delivery of key points and a problem-based learning approach is encouraged so that each participant’s questions are addressed. The program will conclude with a discussion of references and demonstration of some available databases. After all, when an adverse drug reaction occurs due to a drug interaction, who is more at risk – you or your patient?
Objectives to be covered:
Describe the potential for drug-drug interactions and articulate strategies to avoid or manage them.
Understand the principles of drug metabolism including liver enzyme induction and inhibition.
Discuss the role of cytochrome P450 isoenzymes in the liver with respect to drug metabolism
Describe at least three disease states attributable for induced metabolism and three disease states attributable for inhibited metabolism.
Recognize reputable databases and references and how to utilize these tools to evaluate drug therapies and herbal interactions.
Mark Donaldson, BSP, RPH, ACPR, PHARMD, FASHP, FACHE
Mark Donaldson received his baccalaureate degree from the University of British Columbia and his Doctorate in Clinical Pharmacy from the University of Washington. He completed a residency at Vancouver General Hospital, and has practiced as a clinical pharmacy specialist, clinical coordinator and director of pharmacy services at many healthcare organizations in both Canada and the United States. He is currently the Senior Executive Director, Pharmacy Advisory Solutions for Vizient, and lives in Whitefish, Montana.
Dr. Donaldson is a Clinical Professor in the Department of Pharmacy at the University of Montana in Missoula, Clinical Associate Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon and Adjunct Professor, in the Faculty of Dentistry at the University of British Columbia. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. He has spent the last 19 years focusing on dental pharmacology and dental therapeutics, and is a leader in the field.
Dr. Donaldson has published numerous peer-reviewed works and textbook chapters. He currently serves on the Editorial Board for the Journal of the American Dental Association, is board certified in healthcare management and is the Past-President and now Regent of the American College of Healthcare Executives’ Montana Chapter. Dr. Donaldson was named as the 2014 recipient of the Bowl of Hygeia for the state of Montana and is the 2016 recipient of the Dr. Thaddeus V. Weclew Award. This award is conferred upon an individual who has made outstanding contributions to the art and science of dentistry and/or enhanced the principles and ideals of the Academy of General Dentistry.